63 completed, 19 active not recruiting, 18 unknown, 6 not yet recruiting. 45 Not applicable, 14 Phase 3, 13 Phase 2, 6 Phase 4, 5 Phase 1.
Follow Human Papillomavirus Infection: new trials by email Literature Review of Human Papillomavirus Infection trials Research Report on Human Papillomavirus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections | Not applicable | Not yet recruiting | Hifas da Terra S.L. | 81 | 2027-07-01 | 2026-10-05 |
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts Intralesional Acyclovir, Intralesional Zinc Sulphate - Warts, Plantar Warts | Phase 3 | Not yet recruiting | Assiut University | 76 | 2026-10-01 | 2026-09-29 |
| Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression Anal Self-Sampling for High-Risk HPV Detection - Human Papillomavirus Infection, Anal HPV Infection | Not applicable | Not yet recruiting | University Hospital, Montpellier | 190 | 2026-10-01 | 2026-10-05 |
| Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine 10vHPV, Gardasil9 - Human Papillomavirus Infection | Phase 1 / Phase 2 | Not yet recruiting | Serum Institute of India Pvt. Ltd. | 72 | 2026-10-01 | 2026-10-22 |
| ESCUDDO Long Term Follow Up Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Phase 4 | Enrolling by invitation | National Cancer Institute (NCI) | 13700 | 2026-08-11 | 2026-09-22 |
| Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV) Oral Immunomodulator, Vaginal Ovule, Standard Supportive Care - Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia (CIN) | Not applicable | Active not recruiting | Dr. Lutfi Kirdar Kartal Training and Research Hospital | 76 | 2026-04-28 | 2026-07-29 |
| Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women Health Belief Model-Based Education - Cervical Cancer, Human Papillomavirus Infection | Not applicable | Completed | Muhammet Faruk Yigit | 154 | 2026-03-15 | 2026-07-16 |
| Point of Care - Triage and Treatment for Cervical Pre-cancer IRIS™ Thermal Ablation Device - Cervical Precancer, Cervical Intraepithelial Neoplasia | Not applicable | Recruiting | Basic Health International, Inc. | 5000 | 2026-01-01 | 2026-08-28 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Recruiting | National Cancer Institute (NCI) | 500 | 2025-11-24 | 2026-07-31 |
| Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening Best Practice, Communication Intervention, Electronic Health Record Review - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Enrolling by invitation | Mayo Clinic | 500 | 2025-10-07 | 2026-06-09 |
| Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years Cervavac as three dose regimen, Cervavac as two dose regimen, Gardasil as three dose regimen - Human Papillomavirus Infection | Phase 3 | Active not recruiting | Serum Institute of India Pvt. Ltd. | 450 | 2025-10-03 | 2026-06-29 |
| Digital Telecytology for Triage of HPV-Positive Women in Cameroon HPV testing (self-sampling), Digital telecytology, AI-assisted telecytology - Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia Grade 2 (CIN2) | Not applicable | Recruiting | University Hospital, Geneva | 1800 | 2025-09-08 | 2026-04-24 |
| The Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus) Knowledge and Vaccine Awareness in Women "HBM-Based Education and Motivational Interviewing" - Human Papillomavirus Infection | Not applicable | Not yet recruiting | Saglik Bilimleri Universitesi | 60 | 2025-08-01 | 2025-07-31 |
| Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer Pre-Radiation Dental Evaluation/Sample Collection, Pre-Study Visit, Oral Medicine Consultation Visit/Sample Collection - Oropharyngeal Squamous Cell Carcinoma, Human Papillomavirus Infection | Withdrawn | Wake Forest University Health Sciences | 2025-08-01 | 2025-07-31 | ||
| Transmission of Oncogenic HPV Infection Among Families Human Papilloma Virus (HPV), Cervical Carcinoma | Not yet recruiting | Tampere University Hospital | 700 | 2025-08-01 | 2025-06-25 | |
| Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents Facilitator-driven provider- and practice-level implementation strategies for influencing provider recommendations and practice-level HPV vaccination rates - Human Papillomavirus Infection | Not applicable | Recruiting | The University of Texas Health Science Center, Houston | 225 | 2025-03-13 | 2026-05-04 |
| HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population Human Papillomavirus Infection, Human Immunodeficiency Virus Infection | Completed | ANRS, Emerging Infectious Diseases | 200 | 2024-10-15 | 2026-09-02 | |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-13 | 2026-07-07 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-11 | 2026-07-07 |
Showing 20 of 125. Sign in to see all of them.
Papillomavirus Infections (125) · Uterine Cervical Neoplasms (43) · Uterine Cervical Dysplasia (19) · Condylomata Acuminata (11) · Anus Neoplasms (9) · Vaginal Neoplasms (9) · Vulvar Neoplasms (9) · Atypical Squamous Cells of the Cervix (6) · Neoplasms (6) · Squamous Intraepithelial Lesions (5) · Oropharyngeal Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (4) · HIV Infections (3) · Acquired Immunodeficiency Syndrome (2) · Adenocarcinoma in Situ (2)
Communicable Diseases (125) · DNA Virus Infections (125) · Disease Attributes (125) · Genital Diseases (125) · Infections (125) · Pathologic Processes (125) · Pathological Conditions, Signs and Symptoms (125) · Sexually Transmitted Diseases, Viral (125) · Tumor Virus Infections (125) · Urogenital Diseases (125) · Virus Diseases (124) · Sexually Transmitted Diseases (123) · Neoplasms (56) · Neoplasms by Site (53) · Female Urogenital Diseases (51)
Papillomavirus Vaccines (7) · Specimen Handling (7) · Vaccines (7) · Colposcopy (5) · Human Papillomavirus DNA Tests (4) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (4) · Human Papillomavirus Recombinant Vaccine nonavalent (4) · Early Intervention, Educational (3) · Educational Status (3) · Methods (3) · Patient Navigation (3) · Diphtheria Toxoid (2) · Diphtheria-Tetanus-acellular Pertussis Vaccines (2) · Interviews as Topic (2) · Practice Guidelines as Topic (2)
National Cancer Institute (NCI) (10) · Merck Sharp & Dohme LLC (8) · Beijing Health Guard Biotechnology, Inc (4) · GlaxoSmithKline (4) · Baylor College of Medicine (3) · Gen-Probe, Incorporated (3) · Lei Li (3) · Mayo Clinic (3) · Shanghai Zerun Biotechnology Co.,Ltd (3) · The Institute of Molecular and Translational Medicine, Czech Republic (3) · University Hospital, Geneva (3) · Assiut University (2) · Liaquat University of Medical & Health Sciences (2) · M.D. Anderson Cancer Center (2) · McGill University (2)
United States (43) · China (12) · Australia (6) · Canada (5) · Costa Rica (5) · Turkey (Türkiye) (5) · France (4) · Czechia (3) · Kenya (3) · Spain (3) · Belgium (2) · Egypt (2) · Finland (2) · Italy (2) · Puerto Rico (2)
Vikrant V Sahasrabuddhe (4) · Lei Li, M.D. (3) · Yongjiang Liu, Bachelor (3) · Aimee Kreimer (2) · Aimee R Kreimer (2) · Jennifer L Reid, PhD (2) · Marian Hajduch, MD, PhD. (2) · Melissa B Gilkey, PhD (2) · Noel T Brewer, PhD (2) · Paul Reiter, PhD (2) · Alice Lytwyn, MD, FRCPC (1) · Amanda S Bruegl (1)
PMID 41276263, PMID 27422279, PMID 33326342, PMID 17335880, PMID 17628649, PMID 20189491, PMID 20629576, PMID 21973261, PMID 22445557, PMID 23027469, PMID 23462834, PMID 23875668, PMID 23965778, PMID 24276343, PMID 24433684, PMID 24492015, PMID 24812407, PMID 25278227, PMID 25447728, PMID 25466757, PMID 25684487, PMID 25693011, PMID 25749310, PMID 25912208, PMID 26240207, PMID 26290207, PMID 26366475, PMID 27404999, PMID 27893068, PMID 28332888, PMID 28579497, PMID 28789851, PMID 28886907, PMID 29211620, PMID 29269325, PMID 29767739, PMID 30461597, PMID 30852604, PMID 30982556, PMID 31163012, PMID 31264912, PMID 31795926, PMID 32078808, PMID 32205376, PMID 32414376, PMID 32788190, PMID 33271093, PMID 33386332, PMID 33676783, PMID 33857679
U01IP001073 (2), 2016 (1), 2018 (1), N01CM00032 (1), N01CM00038 (1), N01CM00071 (1), N01CM62201 (1), N01CN00035 (1), P01CA229143 (1), P30CA012197 (1), P30CA013330 (1), P30CA015704 (1), P30CA060553 (1), R01CA148966 (1), R01CA157469 (1)